Clinical Trial Update: WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of WTX-330 in patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma has completed enrollment and posted results (as of 2026-01…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• WTX-330

Snippet

Sponsor: Werewolf Therapeutics, Inc. | Conditions: Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2026-01-06